(NYSE: BAX) Baxter International's forecast annual revenue growth rate of -0.57% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.8%.
Baxter International's revenue in 2025 is $11,889,000,000.On average, 6 Wall Street analysts forecast BAX's revenue for 2025 to be $5,826,620,591,766, with the lowest BAX revenue forecast at $5,720,737,271,802, and the highest BAX revenue forecast at $5,869,255,139,444. On average, 7 Wall Street analysts forecast BAX's revenue for 2026 to be $6,040,770,414,642, with the lowest BAX revenue forecast at $5,943,773,226,450, and the highest BAX revenue forecast at $6,114,475,633,045.
In 2027, BAX is forecast to generate $6,227,099,501,682 in revenue, with the lowest revenue forecast at $6,081,822,331,784 and the highest revenue forecast at $6,338,897,159,175.